IRADIMED CORP — Director's Dealing 2021

Nov 18, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IRADIMED CORP (IRMD)
CIK: 0001325618
Period of Report: 2021-11-15

Reporting Person: Scott Christopher K. (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-11-15	Common Stock	A	2027	$9.84	Acquired	30622	Direct
2021-11-15	Common Stock	S	2027	$40.098	Disposed	28595	Direct
2021-11-16	Common Stock	A	4255	$9.84	Acquired	32850	Direct
2021-11-16	Common Stock	S	4255	$40	Disposed	28595	Direct
2021-11-17	Common Stock	A	2003	$9.84	Acquired	30598	Direct
2021-11-17	Common Stock	S	2003	$40.0105	Disposed	28595	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-11-15	Employee Stock Option (Right to Buy)	$9.84	M	2027	Disposed	2024-12-15	Common Stock (2027)	Direct
2021-11-16	Employee Stock Option (Right to Buy)	$9.84	M	4255	Disposed	2024-12-15	Common Stock (4255)	Direct
2021-11-17	Employee Stock Option (Right to Buy)	$9.84	M	2003	Disposed	2024-12-15	Common Stock (2003)	Direct

Footnotes

F1: This transaction was executed in multiple trades at prices ranging from $40.00 to $41.00. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and priced at which the transaction was effected.

F2: This transaction was executed in multiple trades at prices ranging from $40.00 to $40.07. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and priced at which the transaction was effected.

F3: This option was granted on 12-15-2014 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date.